Production and Characterization of Protein Biologics
At the 2024 Protein & Antibody Engineering Summit (PEGS) Europe, Crelux presented a poster highlighting its drug discovery platform for the production and characterization of protein biologics and their antigens. This platform combines construct and expression scouting, customizable high-throughput protein purification, and affinity/kinetics determination using various biophysical techniques, as well as paratope and epitope mapping through structural biology methods. The platform ensures fast turnover, high quality, adherence to high scientific standards, and is tailored for maximal flexibility to streamline the drug discovery process.
Poster_PEGS Europe 2024_Platform for the Production and Characterization of Protein Biologics and Their Antigens
Related Content
High-throughput screening (HTS) remains critical for early drug discovery, yet traditional biochemical assays and specialized techniques such as affinity selection...
VIEW RESOURCEDNA-encoded libraries have become widely used in drug discovery, and several approaches for linking chemical compounds to DNA have been...
VIEW RESOURCE